C4 Therapeutics Company
C4 Therapeutics develops novel early stage therapies that eliminate disease-causing proteins.
Technology:
Genetic Test & Molecular Diagnostics
Industry:
Deep diagnostics
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
1/1/2015
Employees Number:
101-250
Funding Status:
IPO
Total Funding:
423800000
Estimated Revenue:
$1M to $10M
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership